Cronos Group Inc (NASDAQ: CRON) on Friday, soared 3.35% from the previous trading day, before settling in for the closing price of $2.09. Within the past 52 weeks, CRON’s price has moved between $1.72 and $3.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 53.82% over the past five years. The company achieved an average annual earnings per share of 53.71%. With a float of $200.31 million, this company’s outstanding shares have now reached $381.30 million.
Let’s look at the performance matrix of the company that is accounted for 356 employees. In terms of profitability, gross margin is 12.58%, operating margin of -44.07%, and the pretax margin is -57.06%.
Cronos Group Inc (CRON) Insider and Institutional Ownership
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Cronos Group Inc is 47.60%, while institutional ownership is 12.41%.
Cronos Group Inc (CRON) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 53.71% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.80% during the next five years compared to -9.06% drop over the previous five years of trading.
Cronos Group Inc (NASDAQ: CRON) Trading Performance Indicators
Cronos Group Inc (CRON) is currently performing well based on its current performance indicators. A quick ratio of 27.41 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.72. Likewise, its price to free cash flow for the trailing twelve months is 88.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.15, a number that is poised to hit 0.01 in the next quarter and is forecasted to reach 0.01 in one year’s time.
Technical Analysis of Cronos Group Inc (CRON)
Cronos Group Inc (NASDAQ: CRON) saw its 5-day average volume 0.62 million, a negative change from its year-to-date volume of 1.93 million. As of the previous 9 days, the stock’s Stochastic %D was 24.10%. Additionally, its Average True Range was 0.08.
During the past 100 days, Cronos Group Inc’s (CRON) raw stochastic average was set at 19.93%, which indicates a significant decrease from 30.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.34% in the past 14 days, which was higher than the 39.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.19, while its 200-day Moving Average is $2.34. Nevertheless, the first resistance level for the watch stands at $2.20 in the near term. At $2.24, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.30. If the price goes on to break the first support level at $2.11, it is likely to go to the next support level at $2.05. The third support level lies at $2.01 if the price breaches the second support level.
Cronos Group Inc (NASDAQ: CRON) Key Stats
Market capitalization of the company is 1.19 billion based on 382,295K outstanding shares. Right now, sales total 87,240 K and income totals -73,960 K. The company made 27,760 K in profit during its latest quarter, and -8,760 K in sales during its previous quarter.
